Had a rethink here. It is cheap based on H2 projections but,
1) These are just projections at this stage and recent history has been worse.
2) This will stay cheap until it starts to show signs of growth.
Statseeker, Urgent have largely disappointed since they were acquired. ERST has been solid but has limited potential.
These companies do not have much in common and are scattered all over the world so there is no real advantage to having them under one corporate umbrella.
A lot rests on the ability of management and so far I'm yet to be convinced.
TCN Price at posting:
6.5¢ Sentiment: None Disclosure: Not Held
